Back
Invesco S&P MidCap 400® Pure Value ETF Vs. Viking Therapeutics Industry Stock Comparison
Sell
44
RFV
Invesco S&P MidCap 400® Pure Value ETF
Last Price:
110.15
Seasonality Move:
0.93%
Buy
54
VKTX
Viking Therapeutics
Last Price:
51.26
Seasonality Move:
6.26%
Sell
44
Invesco S&P MidCap 400® Pure Value ETF (RFV)
is a Sell
Is Invesco S&P MidCap 400® Pure Value ETF a Buy, Sell or Hold?
- The current Invesco S&P MidCap 400® Pure Value ETF [RFV] share price is $110.07. The Score for RFV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RFV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $51.27. The Score for VKTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RFV Stock Price Chart
What is Invesco S&P MidCap 400® Pure Value ETF's stock price today?
-
The Invesco S&P MidCap 400® Pure Value ETF share price today is $110.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RFV is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $51.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
RFV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.83 | Sell |
Relative Strength Index (14 RSI): | 39.13 | Sell |
Chaikin Money Flow: | -5145 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.77 - 113.87) | Sell |
Bollinger Bands (100): | (111.05 - 115.81) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.92 | Sell |
Relative Strength Index (14 RSI): | 42.17 | Sell |
Chaikin Money Flow: | -7165 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.73 - 57.75) | Sell |
Bollinger Bands (100): | (49.81 - 78.71) | Sell |
RFV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.96 | Sell |
20-day SMA: | 111.71 | Sell |
50-day SMA: | 113.35 | Sell |
200-day SMA: | 108.98 | Buy |
8-day EMA: | 111.04 | Sell |
20-day EMA: | 111.81 | Sell |
50-day EMA: | 112.77 | Sell |
200-day EMA: | 109.76 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.94 | Buy |
20-day SMA: | 52.11 | Sell |
50-day SMA: | 62.69 | Sell |
200-day SMA: | 39.93 | Buy |
8-day EMA: | 51.54 | Sell |
20-day EMA: | 53.48 | Sell |
50-day EMA: | 58.29 | Sell |
200-day EMA: | 45.95 | Buy |
Invesco S&P MidCap 400® Pure Value ETF Earnings Growth & RFV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Invesco S&P MidCap 400® Pure Value ETF Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |